/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES/
TORONTO, Aug. 28, 2018 /CNW/ - TerrAscend Corp. (CSE:TER) ("TerrAscend" or the "Company") is pleased to announce the appointment of Adam Kozak as Chief Financial Officer, effective August 27, 2018.
Mr Kozak brings with him a wealth of experience from Loblaw Companies Limited, where he was most recently Senior Director of Finance. During his tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics.
"Adam will be a tremendous addition to the executive management team at TerrAscend," said Michael Nashat, President and Chief Executive Officer. "His appointment will be instrumental in supporting the next stage of the Company's corporate growth strategy. On behalf of our entire team and the Board of Directors, we thank our departing interim CFO, Roland Nimmo, for his commitment and contributions to TerrAscend and wish him continued success."
Incoming CFO, Adam Kozak remarked on his appointment, "TerrAscend's distinction in a highly crowded market attracted me to the opportunity. The team has accomplished a great deal in their short time together. I'm thrilled to help the Company achieve its strategic goals."
TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals.
Forward Looking Information
This news release contains "forward-looking information" within the meaning of applicable securities laws. Although TerrAscend believes that the experience of its officers and directors, current conditions and expected future developments and other factors have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because TerrAscend can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward- looking information. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release. TerrAscend undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of TerrAscend, its securities, or financial or operating results (as applicable). TerrAscend disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
For further information: Gina DeBenedetti, VP, Communications, 1-855-TERRA-95 x100, firstname.lastname@example.org; Michael Nashat, President and CEO, 1-855 TERRA-95, email@example.com